Tekla Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 143,214 shares of ALNY stock, worth $39.4 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

143,214

Previous 143,214 -0.0%

Holding current value

$39.4 Million

Previous $28.7 Million 5.18%

% of portfolio

1.08%

Previous 1.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$138.54 - $232.0 $2.05 Million - $3.43 Million	14,800 Added 11.53%	143,214 $28.7 Million
Q2 2022 Jul 29, 2022	SELL	$120.42 - $169.29 $3.64 Million - $5.11 Million	-30,192 Reduced 19.04%	128,414 $18.7 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $3.95 Million - $5.41 Million	-31,089 Reduced 16.39%	158,606 $25.9 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $9.37 Million - $11.5 Million	55,200 Added 41.04%	189,695 $35.8 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $2.62 Million - $3.61 Million	-20,407 Reduced 13.17%	134,495 $22.8 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $2.54 Million - $3.51 Million	-19,992 Reduced 11.43%	154,902 $21.9 Million
Q3 2020 Nov 13, 2020	BUY	$121.19 - $165.49 $5.94 Million - $8.11 Million	49,027 Added 38.95%	174,894 $25.5 Million
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $1.22 Million - $1.84 Million	-11,750 Reduced 8.54%	125,867 $18.6 Million
Q1 2020 May 14, 2020	SELL	$93.12 - $133.99 $575,295 - $827,790	-6,178 Reduced 4.3%	137,617 $15 Million
Q4 2019 Feb 13, 2020	SELL	$74.51 - $124.23 $1.67 Million - $2.79 Million	-22,480 Reduced 13.52%	143,795 $16.6 Million
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $347,622 - $430,581	4,903 Added 3.04%	166,275 $13.4 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $1.84 Million - $2.59 Million	27,914 Added 20.92%	161,372 $11.7 Million
Q1 2019 May 14, 2019	BUY	$72.76 - $93.45 $529,838 - $680,502	7,282 Added 5.77%	133,458 $12.5 Million
Q3 2018 Nov 13, 2018	SELL	$87.52 - $122.67 $367,584 - $515,214	-4,200 Reduced 3.22%	126,176 $11 Million
Q1 2018 May 14, 2018	BUY	$115.92 - $148.54 $1.79 Million - $2.29 Million	15,410 Added 13.4%	130,376 $15.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	114,966	114,966 $9.17 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History